SMC
JNJ icon

Smith, Moore & Co’s Johnson & Johnson JNJ Stock Holding History

Smith, Moore & Co’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.43M Sell
22,201
-63
-0.3% -$14.7K 0.39% 55
2025
Q4 		$4.61M Sell
22,264
-1,817
-8% -$359K 0.35% 63
2025
Q3 		$4.47M Buy
24,081
+250
+1% +$42.8K 0.34% 67
2025
Q2 		$3.64M Buy
23,831
+958
+4% +$147K 0.31% 72
2025
Q1 		$3.79M Sell
22,873
-525
-2% -$82.1K 0.35% 63
2024
Q4 		$3.38M Sell
23,398
-692
-3% -$107K 0.31% 70
2024
Q3 		$3.9M Sell
24,090
-788
-3% -$126K 0.37% 56
2024
Q2 		$3.64M Buy
24,878
+512
+2% +$76.1K 0.38% 57
2024
Q1 		$3.85M Sell
24,366
-829
-3% -$132K 0.41% 54
2023
Q4 		$3.93M Sell
25,195
-663
-3% -$102K 0.46% 45
2023
Q3 		$4.01M Buy
25,858
+1,428
+6% +$236K 0.53% 38
2023
Q2 		$4.02M Buy
24,430
+404
+2% +$65.2K 0.51% 39
2023
Q1 		$3.72M Buy
24,026
+351
+1% +$56.7K 0.51% 34
2022
Q4 		$4.18M Buy
23,675
+103
+0.4% +$17.8K 0.58% 32
2022
Q3 		$3.85M Sell
23,572
-136
-0.6% -$23K 0.58% 29
2022
Q2 		$4.21M Sell
23,708
-466
-2% -$83K 0.65% 27
2022
Q1 		$4.28M Buy
24,174
+205
+0.9% +$34.9K 0.58% 32
2021
Q4 		$4.1M Buy
23,969
+177
+0.7% +$29K 0.57% 32
2021
Q3 		$3.84M Sell
23,792
-446
-2% -$76.1K 0.59% 29
2021
Q2 		$4.01M Buy
24,238
+43
+0.2% +$7.12K 0.6% 29
2021
Q1 		$3.98M Buy
24,195
+665
+3% +$108K 0.64% 26
2020
Q4 		$3.68M Sell
23,530
-682
-3% -$101K 0.69% 27
2020
Q3 		$3.6M Buy
24,212
+4,221
+21% +$625K 0.75% 28
2020
Q2 		$2.79M Sell
19,991
-3,401
-15% -$496K 0.62% 36
2020
Q1 		$3.07M Sell
23,392
-1,175
-5% -$167K 0.81% 27
2019
Q4 		$3.58M Sell
24,567
-179
-0.7% -$24.3K 0.74% 30
2019
Q3 		$3.2M Sell
24,746
-1,549
-6% -$204K 0.71% 31
2019
Q2 		$3.66M Sell
26,295
-189
-0.7% -$26.2K 0.82% 28
2019
Q1 		$3.72M Sell
26,484
-3,536
-12% -$474K 0.88% 27
2018
Q4 		$3.87M Sell
30,020
-1,878
-6% -$262K 1.05% 17
2018
Q3 		$4.44M Buy
31,898
+1,259
+4% +$167K 1.01% 19
2018
Q2 		$3.72M Buy
30,639
+705
+2% +$88K 0.93% 20
2018
Q1 		$3.84M Sell
29,934
-452
-1% -$61.1K 1.03% 18
2017
Q4 		$4.25M Sell
30,386
-492
-2% -$68.5K 1.14% 15
2017
Q3 		$4.01M Buy
30,878
+7,826
+34% +$1.04M 1.14% 15
2017
Q2 		$3.05M Buy
23,052
+225
+1% +$28.7K 1.02% 20
2017
Q1 		$2.84M Sell
22,827
-206
-0.9% -$24.6K 1.02% 20
2016
Q4 		$2.65M Sell
23,033
-249
-1% -$28.8K 1.01% 19
2016
Q3 		$2.75M Buy
23,282
+723
+3% +$87.7K 1.11% 20
2016
Q2 		$2.74M Sell
22,559
-376
-2% -$42.7K 1.13% 21
2016
Q1 		$2.48M Buy
22,935
+6,040
+36% +$625K 1.07% 25
2015
Q4 		$1.74M Buy
16,895
+5,327
+46% +$536K 0.86% 25
2015
Q3 		$1.08M Buy
11,568
+911
+9% +$88.1K 0.6% 26
2015
Q2 		$1.04M Buy
10,657
+430
+4% +$43.1K 0.53% 32
2015
Q1 		$1.03M Buy
10,227
+134
+1% +$13.6K 0.54% 28
2014
Q4 		$1.06M Buy
10,093
+310
+3% +$32.7K 0.56% 31
2014
Q3 		$1.04M Buy
9,783
+4,560
+87% +$473K 0.58% 33
2014
Q2 		$546K Sell
5,223
-3,501
-40% -$354K 0.33% 49
2014
Q1 		$857K Sell
8,724
-832
-9% -$77.1K 0.51% 36
2013
Q4 		$875K Buy
+9,556
New +$881K 0.55% 33

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Smith, Moore & Co's JNJ Position: Q1 2026 in Review

Smith, Moore & Co reduced its Johnson & Johnson (JNJ) stake by 0.28% in Q1 2026, selling an estimated $14.7K and leaving 22,201 shares worth $5.43M. The position accounts for 0.39% of the portfolio, ranked #55.

Smith, Moore & Co first reported a position in JNJ in Q4 2013 and has held it in 50 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Smith, Moore & Co held 22,201 shares of Johnson & Johnson worth $5.43M as of Q1 2026.
  • Smith, Moore & Co sold 63 Johnson & Johnson shares in Q1 2026, an estimated $14.7K.
  • Johnson & Johnson made up 0.39% of Smith, Moore & Co's portfolio in Q1 2026, its #55 holding.
  • Smith, Moore & Co first reported a position in Johnson & Johnson in Q4 2013 and has held it in 50 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Smith, Moore & Co's 13F filing for Q1 2026, filed 5 May 2026.